EXPEDIA GROUP INC (EXPE) Stock Fundamental Analysis

NASDAQ:EXPE • US30212P3038

215.69 USD
-2.24 (-1.03%)
At close: Feb 27, 2026
215.69 USD
0 (0%)
After Hours: 2/27/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to EXPE. EXPE was compared to 126 industry peers in the Hotels, Restaurants & Leisure industry. While EXPE has a great profitability rating, there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on EXPE. These ratings could make EXPE a good candidate for value investing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • In the past year EXPE was profitable.
  • EXPE had a positive operating cash flow in the past year.
  • Of the past 5 years EXPE 4 years were profitable.
  • In the past 5 years EXPE always reported a positive cash flow from operatings.
EXPE Yearly Net Income VS EBIT VS OCF VS FCFEXPE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B -4B

1.2 Ratios

  • EXPE has a better Return On Assets (5.29%) than 70.63% of its industry peers.
  • EXPE has a Return On Equity of 100.78%. This is amongst the best in the industry. EXPE outperforms 96.03% of its industry peers.
  • The Return On Invested Capital of EXPE (22.36%) is better than 91.27% of its industry peers.
  • EXPE had an Average Return On Invested Capital over the past 3 years of 16.54%. This is significantly above the industry average of 10.67%.
  • The last Return On Invested Capital (22.36%) for EXPE is above the 3 year average (16.54%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.29%
ROE 100.78%
ROIC 22.36%
ROA(3y)4.83%
ROA(5y)2.97%
ROE(3y)77.33%
ROE(5y)46.87%
ROIC(3y)16.54%
ROIC(5y)12.05%
EXPE Yearly ROA, ROE, ROICEXPE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100 -100

1.3 Margins

  • With a decent Profit Margin value of 8.78%, EXPE is doing good in the industry, outperforming 69.84% of the companies in the same industry.
  • In the last couple of years the Profit Margin of EXPE has grown nicely.
  • EXPE has a Operating Margin of 14.68%. This is in the better half of the industry: EXPE outperforms 65.87% of its industry peers.
  • In the last couple of years the Operating Margin of EXPE has grown nicely.
  • With an excellent Gross Margin value of 90.12%, EXPE belongs to the best of the industry, outperforming 98.41% of the companies in the same industry.
  • EXPE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 14.68%
PM (TTM) 8.78%
GM 90.12%
OM growth 3Y12.94%
OM growth 5YN/A
PM growth 3Y42.79%
PM growth 5YN/A
GM growth 3Y1.65%
GM growth 5Y5.89%
EXPE Yearly Profit, Operating, Gross MarginsEXPE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so EXPE is creating value.
  • EXPE has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, EXPE has less shares outstanding
  • Compared to 1 year ago, EXPE has an improved debt to assets ratio.
EXPE Yearly Shares OutstandingEXPE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
EXPE Yearly Total Debt VS Total AssetsEXPE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

  • EXPE has an Altman-Z score of 1.46. This is a bad value and indicates that EXPE is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.46, EXPE is in line with its industry, outperforming 47.62% of the companies in the same industry.
  • EXPE has a debt to FCF ratio of 1.98. This is a very positive value and a sign of high solvency as it would only need 1.98 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 1.98, EXPE belongs to the best of the industry, outperforming 84.92% of the companies in the same industry.
  • A Debt/Equity ratio of 3.48 is on the high side and indicates that EXPE has dependencies on debt financing.
  • EXPE has a Debt to Equity ratio (3.48) which is in line with its industry peers.
  • Even though the debt/equity ratio score it not favorable for EXPE, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 3.48
Debt/FCF 1.98
Altman-Z 1.46
ROIC/WACC2.89
WACC7.74%
EXPE Yearly LT Debt VS Equity VS FCFEXPE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B -4B 6B 8B

2.3 Liquidity

  • EXPE has a Current Ratio of 0.73. This is a bad value and indicates that EXPE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • EXPE has a Current ratio of 0.73. This is in the lower half of the industry: EXPE underperforms 66.67% of its industry peers.
  • EXPE has a Quick Ratio of 0.73. This is a bad value and indicates that EXPE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of EXPE (0.73) is worse than 63.49% of its industry peers.
Industry RankSector Rank
Current Ratio 0.73
Quick Ratio 0.73
EXPE Yearly Current Assets VS Current LiabilitesEXPE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 30.64% over the past year.
  • EXPE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 32.98% yearly.
  • Looking at the last year, EXPE shows a small growth in Revenue. The Revenue has grown by 7.61% in the last year.
  • The Revenue has been growing by 23.16% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)30.64%
EPS 3Y32.98%
EPS 5YN/A
EPS Q2Q%58.16%
Revenue 1Y (TTM)7.61%
Revenue growth 3Y8.09%
Revenue growth 5Y23.16%
Sales Q2Q%11.4%

3.2 Future

  • EXPE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.31% yearly.
  • Based on estimates for the next years, EXPE will show a small growth in Revenue. The Revenue will grow by 6.67% on average per year.
EPS Next Y15.85%
EPS Next 2Y17.69%
EPS Next 3Y14.71%
EPS Next 5Y13.31%
Revenue Next Year8.51%
Revenue Next 2Y7.75%
Revenue Next 3Y7.57%
Revenue Next 5Y6.67%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
EXPE Yearly Revenue VS EstimatesEXPE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B
EXPE Yearly EPS VS EstimatesEXPE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 10 20 30 40

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • EXPE is valuated correctly with a Price/Earnings ratio of 13.49.
  • EXPE's Price/Earnings ratio is rather cheap when compared to the industry. EXPE is cheaper than 81.75% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of EXPE to the average of the S&P500 Index (27.10), we can say EXPE is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 11.64, the valuation of EXPE can be described as reasonable.
  • 83.33% of the companies in the same industry are more expensive than EXPE, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, EXPE is valued rather cheaply.
Industry RankSector Rank
PE 13.49
Fwd PE 11.64
EXPE Price Earnings VS Forward Price EarningsEXPE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, EXPE is valued a bit cheaper than 71.43% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of EXPE indicates a rather cheap valuation: EXPE is cheaper than 95.24% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.5
EV/EBITDA 8.79
EXPE Per share dataEXPE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The excellent profitability rating of EXPE may justify a higher PE ratio.
  • A more expensive valuation may be justified as EXPE's earnings are expected to grow with 14.71% in the coming years.
PEG (NY)0.85
PEG (5Y)N/A
EPS Next 2Y17.69%
EPS Next 3Y14.71%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • EXPE has a yearly dividend return of 0.88%, which is pretty low.
  • EXPE's Dividend Yield is a higher than the industry average which is at 1.09.
  • Compared to an average S&P500 Dividend Yield of 1.83, EXPE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.88%

5.2 History

  • The dividend of EXPE has a limited annual growth rate of 3.43%.
  • EXPE has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)3.43%
Div Incr Years0
Div Non Decr Years0
EXPE Yearly Dividends per shareEXPE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2025 2026 0.5 1 1.5

5.3 Sustainability

  • EXPE pays out 15.46% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of EXPE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP15.46%
EPS Next 2Y17.69%
EPS Next 3Y14.71%
EXPE Yearly Income VS Free CF VS DividendEXPE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B -4B
EXPE Dividend Payout.EXPE Dividend Payout, showing the Payout Ratio.EXPE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

EXPEDIA GROUP INC

NASDAQ:EXPE (2/27/2026, 8:00:02 PM)

After market: 215.69 0 (0%)

215.69

-2.24 (-1.03%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)02-12
Earnings (Next)05-06
Inst Owners103.43%
Inst Owner Change-5.25%
Ins Owners0.52%
Ins Owner Change0.52%
Market Cap26.43B
Revenue(TTM)14.73B
Net Income(TTM)1.29B
Analysts72.73
Price Target287.13 (33.12%)
Short Float %6.49%
Short Ratio3.51
Dividend
Industry RankSector Rank
Dividend Yield 0.88%
Yearly Dividend1.59
Dividend Growth(5Y)3.43%
DP15.46%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-05
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.86%
Min EPS beat(2)7.27%
Max EPS beat(2)10.44%
EPS beat(4)4
Avg EPS beat(4)10.03%
Min EPS beat(4)1.46%
Max EPS beat(4)20.96%
EPS beat(8)7
Avg EPS beat(8)31.73%
EPS beat(12)10
Avg EPS beat(12)-8.54%
EPS beat(16)12
Avg EPS beat(16)-5.19%
Revenue beat(2)2
Avg Revenue beat(2)1.39%
Min Revenue beat(2)1.05%
Max Revenue beat(2)1.72%
Revenue beat(4)3
Avg Revenue beat(4)0.01%
Min Revenue beat(4)-2.83%
Max Revenue beat(4)1.72%
Revenue beat(8)5
Avg Revenue beat(8)-0.24%
Revenue beat(12)5
Avg Revenue beat(12)-0.65%
Revenue beat(16)6
Avg Revenue beat(16)-0.67%
PT rev (1m)1.37%
PT rev (3m)7.14%
EPS NQ rev (1m)40.05%
EPS NQ rev (3m)50.77%
EPS NY rev (1m)0.03%
EPS NY rev (3m)7.09%
Revenue NQ rev (1m)2.83%
Revenue NQ rev (3m)2.8%
Revenue NY rev (1m)1.15%
Revenue NY rev (3m)3.94%
Valuation
Industry RankSector Rank
PE 13.49
Fwd PE 11.64
P/S 1.79
P/FCF 8.5
P/OCF 6.81
P/B 20.58
P/tB N/A
EV/EBITDA 8.79
EPS(TTM)15.99
EY7.41%
EPS(NY)18.53
Fwd EY8.59%
FCF(TTM)25.38
FCFY11.77%
OCF(TTM)31.67
OCFY14.68%
SpS120.24
BVpS10.48
TBVpS-52.29
PEG (NY)0.85
PEG (5Y)N/A
Graham Number61.4
Profitability
Industry RankSector Rank
ROA 5.29%
ROE 100.78%
ROCE 27.75%
ROIC 22.36%
ROICexc 84.52%
ROICexgc N/A
OM 14.68%
PM (TTM) 8.78%
GM 90.12%
FCFM 21.11%
ROA(3y)4.83%
ROA(5y)2.97%
ROE(3y)77.33%
ROE(5y)46.87%
ROIC(3y)16.54%
ROIC(5y)12.05%
ROICexc(3y)45.61%
ROICexc(5y)30.79%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)20.53%
ROCE(5y)14.96%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y80.26%
ROICexc growth 5YN/A
OM growth 3Y12.94%
OM growth 5YN/A
PM growth 3Y42.79%
PM growth 5YN/A
GM growth 3Y1.65%
GM growth 5Y5.89%
F-Score7
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 3.48
Debt/FCF 1.98
Debt/EBITDA 1.47
Cap/Depr 86.81%
Cap/Sales 5.23%
Interest Coverage 250
Cash Conversion 127.21%
Profit Quality 240.34%
Current Ratio 0.73
Quick Ratio 0.73
Altman-Z 1.46
F-Score7
WACC7.74%
ROIC/WACC2.89
Cap/Depr(3y)93.95%
Cap/Depr(5y)89.62%
Cap/Sales(3y)5.78%
Cap/Sales(5y)6.17%
Profit Quality(3y)220.15%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.64%
EPS 3Y32.98%
EPS 5YN/A
EPS Q2Q%58.16%
EPS Next Y15.85%
EPS Next 2Y17.69%
EPS Next 3Y14.71%
EPS Next 5Y13.31%
Revenue 1Y (TTM)7.61%
Revenue growth 3Y8.09%
Revenue growth 5Y23.16%
Sales Q2Q%11.4%
Revenue Next Year8.51%
Revenue Next 2Y7.75%
Revenue Next 3Y7.57%
Revenue Next 5Y6.67%
EBIT growth 1Y29.99%
EBIT growth 3Y22.07%
EBIT growth 5YN/A
EBIT Next Year100.89%
EBIT Next 3Y34.47%
EBIT Next 5Y24.3%
FCF growth 1Y33.53%
FCF growth 3Y3.83%
FCF growth 5YN/A
OCF growth 1Y25.77%
OCF growth 3Y4.09%
OCF growth 5YN/A

EXPEDIA GROUP INC / EXPE FAQ

Can you provide the ChartMill fundamental rating for EXPEDIA GROUP INC?

ChartMill assigns a fundamental rating of 7 / 10 to EXPE.


What is the valuation status of EXPEDIA GROUP INC (EXPE) stock?

ChartMill assigns a valuation rating of 8 / 10 to EXPEDIA GROUP INC (EXPE). This can be considered as Undervalued.


Can you provide the profitability details for EXPEDIA GROUP INC?

EXPEDIA GROUP INC (EXPE) has a profitability rating of 9 / 10.


What is the financial health of EXPEDIA GROUP INC (EXPE) stock?

The financial health rating of EXPEDIA GROUP INC (EXPE) is 5 / 10.


Is the dividend of EXPEDIA GROUP INC sustainable?

The dividend rating of EXPEDIA GROUP INC (EXPE) is 5 / 10 and the dividend payout ratio is 15.46%.